Abel Hall LLC’s Pfizer PFE Stock Holding History

Abel Hall LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$978K	Sell	40,621 -3,091	-7%	-$80.9K	0.17%	86
2026 Q1	$1.23M	Buy	43,712 +15,988	+58%	+$426K	0.26%	55
2025 Q4	$690K	Buy	27,724 +1,382	+5%	+$34.9K	0.16%	103
2025 Q3	$671K	Buy	26,342 +442	+2%	+$10.9K	0.27%	53
2025 Q2	$628K	Buy	25,900 +14,395	+125%	+$336K	0.29%	58
2025 Q1	$292K	Buy	11,505 +3,378	+42%	+$88.4K	0.18%	105
2024 Q4	$216K	Sell	8,127 -4,377	-35%	-$119K	0.14%	121
2024 Q3	$362K	Buy	12,504 +62	+0.5%	+$1.81K	0.24%	70
2024 Q2	$348K	Sell	12,442 -354	-3%	-$9.75K	0.25%	73
2024 Q1	$355K	Buy	12,796 +1,456	+13%	+$40.4K	0.27%	64
2023 Q4	$326K	Buy	+11,340	New	+$343K	0.28%	64

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Abel Hall LLC's PFE Position: Q2 2026 in Review

Abel Hall LLC reduced its Pfizer (PFE) stake by 7.1% in Q2 2026, selling an estimated $80.9K and leaving 40,621 shares worth $978K. The position accounts for 0.17% of the portfolio, ranked #86.

Abel Hall LLC first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.23M in Q1 2026. 1,091 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Abel Hall LLC held 40,621 shares of Pfizer worth $978K as of Q2 2026.
Abel Hall LLC sold 3,091 Pfizer shares in Q2 2026, an estimated $80.9K.
Pfizer made up 0.17% of Abel Hall LLC's portfolio in Q2 2026, its #86 holding.
Abel Hall LLC first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
Abel Hall LLC's Pfizer position peaked at $1.23M in Q1 2026.
1,091 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.